Philips Showcases Tele-Ultrasound at AIUM Virtual Event

Royal Philips announced its participation in the upcoming Annual Integrative Ultrasound Meeting (AIUM) virtual event, April 11-14, hosted by the American Institute of Ultrasound in Medicine.

FUJIFILM Healthcare starts to operate as Fujifilm Group company

Adding CT/MRI and other medical devices to the lineup to globally provide value-added solutions based on medical IT

Hyperfine Launches ‘Total Rethink Buying Process’

Hyperfine Research announced in a press release that it is pioneering a wholesale simplification of the capital equipment purchasing experience with the launch of its Total Rethink Buying Process.

Cardinal Health Launches Navista TS

Cardinal Health Specialty Solutions has launched Cardinal Health Navista™ Tech Solutions (TS), an advanced suite of technology solutions to help community oncologists improve outcomes and costs associated with patient treatment as they transition to value-based care.

Personal Genome Diagnostics, Almac Diagnostic Services Team Up

Personal Genome Diagnostics, Almac Diagnostic Services Team UpPersonal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, has announced a strategic collaboration with Almac Diagnostic Services, a global stratified medicine company, to enhance opportunities for clinical trial development and companion diagnostic (CDx) projects.

PGDx and Almac Diagnostic Services will focus on providing access to tumor profiling assays for both tissue and plasma samples, specifically, PGDx elio tissue complete and PGDx elio plasma resolve. This collaboration will combine Almac’s world-class genomics services and expertise in development and delivery of molecular diagnostics with PGDx’s leadership in cancer genomics to accelerate solutions that will deliver precision medicine to more patients.

“We are proud to enter into this strategic collaboration with Almac. Their longstanding reputation for providing high quality lab services to patients worldwide, along with their proven track record of implementing new technologies make this partnership ideal,” said Megan Bailey, CEO, PGDx. “As we continue our quest to empower the fight against cancer, collaborating with Almac will allow us to deliver precision medicine solutions to a broader population and advance innovations in next-generation sequencing technology.”

Almac Diagnostic Services Global Vice President of Commercial Operations Michael Sloan said, “This collaboration with PGDx will enable Almac to provide our Pharmaceutical and Biotech partners with tissue and liquid biopsy options to support their translational research, clinical trials and CDx development requirements. The assay panels PGDx has developed will allow our clients to access world-class next generation sequencing science and bioinformatics solutions.”



Submit a Comment

Your email address will not be published. Required fields are marked *